文献速递头颈部肿瘤放疗

既往放疗后复发或第二原发头颈癌的再治疗:美国镭学会适宜使用标准执行摘要

Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2022-04-08

美国镭学会针对既往照射野内复发或第二原发头颈癌的再治疗制定适宜使用标准,通过系统文献检索(保留274条引文)并经改良Delphi法盲投票形成5个关键问题的共识推荐,涵盖患者选择、辅助再照射、根治性再照射、立体定向体部放疗及非鳞癌再照射。

要点

  • 既往照射野内复发或第二原发头颈癌的再治疗复杂,现有指南较少。
  • 通过系统文献检索和改良Delphi法盲投票形成5个关键问题的共识推荐。
  • 共识投票结果结合最新证据,提供再治疗的循证推荐和指南。

核心结论

  • 该执行摘要提供针对复发或第二原发头颈癌再治疗的更新循证推荐和指南。

研究设计与样本

  • 美国镭学会通过面板共识形成检索词、关键问题及临床病例变体,以系统方式对同行评议期刊进行更新文献检索。
  • 最终保留274条引文供审查,经改良Delphi法盲投票评估治疗选项的适宜性。

主要发现

  • 274条引文形成5个关键问题,聚焦患者选择、辅助再照射、根治性再照射、立体定向体部放疗及非鳞癌再照射。
  • 共识投票结果与最新证据讨论一并呈现。

关键数值与推荐

  • 5个关键问题涵盖患者选择、辅助再照射、根治性再照射、立体定向体部放疗及非鳞癌再照射。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Retreatment of recurrent or second primary head and neck cancers occurring in a previously irradiated field is complex. Few guidelines exist to support practice. We performed an updated literature search of peer-reviewed journals in a systematic fashion. Search terms, key questions, and associated clinical case variants were formed by panel consensus. The literature search informed the committee during a blinded vote on the appropriateness of treatment options via the modified Delphi method. The final number of citations retained for review was 274. These informed 5 key questions, which focused on patient selection, adjuvant reirradiation, definitive reirradiation, stereotactic body radiation, and reirradiation to treat nonsquamous cancer. Results of the consensus voting are presented along with discussion of the most current evidence. This provides updated evidence-based recommendations and guidelines for the retreatment of recurrent or second primary cancer of the head and neck.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Ward MC, Koyfman SA, Bakst RL, et al. Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria. Int J Radiat Oncol Biol Phys. 2022. PMID: 35398456. doi:10.1016/j.ijrobp.2022.03.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。